Everfront Biotech Inc.- Rising Star in Pharmaceutical Innovation

EFB is committed to fulfilling unmet medical needs
by developing orphan drugs to treat the world’s most lethal diseases including high grade glioma and pancreatic cancer
Brain Tumor (Glioblastoma, GBM) and Pancreatic Cancer (PC)
EFB'S Mission
EFB’s Mission

EFB is committed to fulfilling unmet medical needs

About EFB
Rising Star in Pharmaceutical Innovation
Rising Star in Pharmaceutical Innovation

EFB is committed to fulfilling unmet medical needs by developing orphan drugs to treat the world’s most lethal diseases.

Cerebraca® Wafer
Curing Rare Cancer
Curing Rare Cancers

Including
Glioblastoma (GBM) and
Pancreatic cancer (PC)

EF-009 | PC Treatment
previous arrow
next arrow

PRODUCT HIGHLIGHTS of Cerebraca® Wafer

A Biodegradable Implant Targeting GBM with One-month Sustained Drug Release

Latest News

Explore Everfront Biotech

About Everfront
Video News
Scientific Publications

We want to hear from you.

Contact us

Development Pipeline

Pepline - EF-001
EF-001
Pepline - EF-009
EF-009
Pepline - HK-001
HK-001
Pepline - EF-031
EF-031